Sodium 4-{[(6alpha,11beta)-11,17-dihydroxy-6-methyl-3,20-dioxopregna-1,4-dien-21-yl]oxy}-4-oxobutanoate(CAS: 2375-03-3)

Sodium 4-{[(6alpha,11beta)-11,17-dihydroxy-6-methyl-3,20-dioxopregna-1,4-dien-21-yl]oxy}-4-oxobutanoate (CAS: 2375-03-3) is subject to regulatory guidelines such as GHS for classification and labeling, REACH for registration, evaluation, and authorization of chemicals, and FDA/EPA requirements for safety and environmental protection. Compliance with these regulations is essential for proper handling and transportation.

There are several alternatives to Sodium 4-{[(6alpha,11beta)-11,17-dihydroxy-6-methyl-3,20-dioxopregna-1,4-dien-21-yl]oxy}-4-oxobutanoate (CAS: 2375-03-3) in synthesis, such as analogs like 17α,21-dihydroxy-11-methylpregna-1,4-diene-3,20-dione, and isomers like 11β,21-dihydroxy-6α-methylpregna-1,4-diene-3,20-dione. Common alternative reagents include various steroid intermediates and precursors that can be used as substitutes depending on the specific synthetic pathway.

The market for Sodium 4-{[(6alpha,11beta)-11,17-dihydroxy-6-methyl-3,20-dioxopregna-1,4-dien-21-yl]oxy}-4-oxobutanoate (CAS: 2375-03-3) is driven by its applications in pharmaceuticals and research. Recent trends indicate a growing interest in natural product analogs and bioactive compounds. Research is focusing on the development of new synthetic methods and the exploration of potential therapeutic applications, particularly in the field of hormone research and drug discovery.

Waste containing Sodium 4-{[(6alpha,11beta)-11,17-dihydroxy-6-methyl-3,20-dioxopregna-1,4-dien-21-yl]oxy}-4-oxobutanoate (CAS: 2375-03-3) should be collected in a closed, labeled container and stored in a secure, well-ventilated area. Proper disposal methods include incineration or professional waste disposal services that comply with environmental regulations. Environmental protection precautions include minimizing spillage and ensuring that all waste is handled and disposed of in accordance with local and national guidelines.